Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Harpoon Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −11 vs. Q2 2023
- Shares held
- 1.87M
- +209.9K (+12.6%) vs. Q2 2023Converted for a 1-for-10 split
- Total value
- $7.53M
- −$4.25M (−36.1%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 14
- 10 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 41 | $175.5M |
| Q3 2023 | 32 | $7.53M |
| Q2 2023 | 44 | $12.0M |
| Q1 2023 | 46 | $12.9M |
| Q4 2022 | 49 | $13.7M |
| Q3 2022 | 52 | $21.0M |
| Q2 2022 | 63 | $43.4M |
| Q1 2022 | 79 | $128.2M |
| Q4 2021 | 84 | $196.3M |
| Q3 2021 | 93 | $203.9M |
| Q2 2021 | 85 | $357.3M |
| Q1 2021 | 88 | $562.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Oncology Impact Management LP | 319,670 | $1.29M | 0.34% | 00.0% | UnchangedConverted for a 1-for-10 split |
| New Leaf Venture Partners, L.L.C. | 315,668 | $1.27M | 1.63% | 00.0% | UnchangedConverted for a 1-for-10 split |
| MPM Asset Management LLC | 313,136 | $1.26M | 0.68% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Sio Capital Management, LLC | 168,017 | $677.1K | 0.21% | +168,017 | New |
| Franklin Resources Inc | 132,327 | $533.3K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Vanguard Group Inc | 113,362 | $456.8K | 0.00% | −1,953−1.7% | ReducedConverted for a 1-for-10 split |
| Artal Group S.A. | 100,000 | $403.0K | 0.02% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Lion Point Capital, LP | 82,458 | $332.3K | 0.30% | +36,807+80.6% | AddedConverted for a 1-for-10 split |
| OrbiMed Advisors LLC | 62,121 | $250.3K | 0.01% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Cormorant Asset Management, LP | 54,060 | $217.9K | 0.01% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Kennedy Capital Management, Inc. | 52,987 | $213.5K | 0.01% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Citadel Advisors LLC | 48,756 | $196.5K | 0.00% | +48,119+7,550.4% | AddedConverted for a 1-for-10 split |
| BlackRock Inc. | 36,939 | $148.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 24,913 | $100.4K | 0.00% | +3,270+15.1% | AddedConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 24,856 | $100.0K | 0.00% | +3,496+16.4% | AddedConverted for a 1-for-10 split |
| Millennium Management LLC | 10,675 | $43.0K | 0.00% | −5,945−35.8% | ReducedConverted for a 1-for-10 split |
| Acadian Asset Management LLC | 7,670 | $29.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 706 | $2.85K | 0.00% | −641−47.6% | ReducedConverted for a 1-for-10 split |
| Morgan Stanley | 471 | $1.90K | 0.00% | −102−17.7% | ReducedConverted for a 1-for-10 split |
| Group One Trading, L.P. | 383 | $1.54K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Federation des caisses Desjardins du Quebec | 200 | $806 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| JPMorgan Chase & Co | 134 | $557 | 0.00% | −2−1.7% | ReducedConverted for a 1-for-10 split |
| Advisor Group Holdings, Inc. | 107 | $430 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Wells Fargo & Company | 91 | $367 | 0.00% | +4+4.2% | AddedConverted for a 1-for-10 split |
| Bank of America Corp | 75 | $302 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| UBS Group AG | 54 | $218 | 0.00% | −260−82.8% | ReducedConverted for a 1-for-10 split |
| Allworth Financial LP | 40 | $162 | 0.00% | +40 | New |
| US Bancorp | 8 | $32 | 0.00% | −1−10.1% | ReducedConverted for a 1-for-10 split |
| Beaird Harris Wealth Management, LLC | 7 | $29 | 0.00% | −1−6.7% | ReducedConverted for a 1-for-10 split |
| Qube Research & Technologies Ltd | 5 | $20 | 0.00% | +5 | New |
| Royal Bank of Canada | 80 | $0 | 0.00% | −4−5.1% | ReducedConverted for a 1-for-10 split |
| Hantz Financial Services, Inc. | 2 | $0 | 0.00% | −0−9.1% | ReducedConverted for a 1-for-10 split |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −8,800−100.0% | Sold outConverted for a 1-for-10 split |
| State Street Corp | 0 | $0 | 0.00% | −8,523−100.0% | Sold outConverted for a 1-for-10 split |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −6,396−100.0% | Sold outConverted for a 1-for-10 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −4,314−100.0% | Sold outConverted for a 1-for-10 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,766−100.0% | Sold outConverted for a 1-for-10 split |
| Barclays PLC | 0 | $0 | 0.00% | −3,379−100.0% | Sold outConverted for a 1-for-10 split |
| Synovus Financial Corp | 0 | $0 | 0.00% | −2,300−100.0% | Sold outConverted for a 1-for-10 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −1,673−100.0% | Sold outConverted for a 1-for-10 split |
| HRT Financial LP | 0 | $0 | 0.00% | −1,089−100.0% | Sold outConverted for a 1-for-10 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −374−100.0% | Sold outConverted for a 1-for-10 split |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −113−100.0% | Sold outConverted for a 1-for-10 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −43−100.0% | Sold outConverted for a 1-for-10 split |
| FMR LLC | 0 | $0 | 0.00% | −14−100.0% | Sold outConverted for a 1-for-10 split |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-10 split |
| Tekla Capital Management LLC | – | – | – | – | Not filed |